ZUMZ — what changed in the latest 10-Q
A section-by-section comparison of ZUMZ's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-06-04 vs the prior 10-Q · 2025-12-04
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +19 | −29 | ~10 | 88 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +4 | −2 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-06-04
Fiscal 2026 is the 52-week period ending January 30, 2027. Fiscal 2025 was the 52-week period ending January 31, 2026. The first three months of fiscal 2026 was the 13-week period ended May 2, 2026. The first three months of fiscal 2025 was the 13-week period ended May 3, 2025.
The following table presents selected items on the condensed consolidated statements of loss as a percent of net sales:
Three Months (13 weeks) Ended May 2, 2026 Compared With Three Months (13 weeks) Ended May 3, 2025
Net sales were $193.3 million for the three months ended May 2, 2026 compared to $184.3 million for the three months ended May 3, 2025, an increase of $9.0 million, or 4.9%. The increase in sales was primarily driven by a 4.0% increase in comparable sales and impact of foreign exchange rate, partial…
Comparable sales increased 4.0% (reflecting a 4.4% increase in North America and a 2.2% increase in other international) for the three months ended May 2, 2026, driven by an increase in dollars per transaction, partially offset by a decrease in transactions. Dollars per transaction increased due to …
Text removed vs the prior filing · source: 10-Q · 2025-12-04
Fiscal 2025 is the 52-week period ending January 31, 2026. Fiscal 2024 was the 52-week period ending February 1, 2025. The first nine months of fiscal 2025 was the 39-week period ended November 1, 2025. The first nine months of fiscal 2024 was the 39-week period ended November 2, 2024.
Trends and Uncertainties Affecting Our Results and Comparability
We have been, and we expect to continue to be affected by a number of factors that may cause actual results to differ from our historical results or current expectations. These factors include the impact of foreign currency rates; changes in laws, including U.S. tax law changes; fluctuations in vari…
The following table presents selected items on the condensed consolidated statements of income (loss) as a percent of net sales:
Three Months (13 weeks) Ended November 1, 2025 Compared With Three Months (13 weeks) Ended November 2, 2024
Other information
Text added vs the prior filing · source: 10-Q · 2026-06-04
defined in Item 408(a) of SEC Regulation S-K, except as described below:
On April 15, 2026, Mr. Chris K. Visser, the Company’s Chief Legal Officer and Secretary, terminated a previously disclosed trading arrangement and adopted a new trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) under the Securities Exchange Act of 1…
On April 17, 2026, Mr. Christopher C. Work, the Company’s Chief Financial Officer, terminated a previously disclosed trading arrangement and adopted a new trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) under the Securities Exchange Act of 1934. T…
On April 20, 2026, Ms. Erin Wendte, the Company’s Chief Commercial Officer, adopted a trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) under the Securities Exchange Act of 1934. The trading arrangement has a termination date of April 30, 2027, and …
Text removed vs the prior filing · source: 10-Q · 2025-12-04
On October 3, 2025, Mr. Thomas Campion, the Company’s Chairman of the Board, adopted a trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of the Securities Exchange Act Rule 10b5-1…
On September 11, 2025, Mr. Guy Harkless, a member of the Company’s Board of Directors, adopted a trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of the Securities Exchange Act R…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice